Bharat Immunological & Biological Corporation Ltd

AI
Bharat Immunolog Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Bharat Immunological & Biological Corporation Ltd

₹ 9.27 0.98%
23 Oct - close price
bibcol.com BSE: 524663
About

Incorporated in 1989, Bharat Immunological and Biologicals Corporation Ltd manufactures biotechnology-based pharmaceuticals.[1]

Key Points

Business Overview:[1][2]
BIBCL is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science & Technology, Government of India, undertaking. It was established as a Public Sector Unit to achieve the production and supply of high-quality polio vaccine. The company had captured 60% of the total market share and was among the top 20 Biotech companies in Indiain India. Currently, it manufactures and produces a range of pharmaceutical products such as:
a) Oral Polio Vaccines (OPV Vaccine)
b) Diarrhea Management Kits
c) BIB Sweet Tablets
d) Hepatitis B vaccine
e) Zinc Tablets, etc.
In FY16, the company switched over to bOPV from tOPV. To add in product line, the company diversified into plasma-derived medicines and the Oral Cholera Vaccine.

Website BSE
  • Market Cap ₹ 40.0 Cr.
  • Current Price ₹ 9.27
  • High / Low ₹ 22.6 / 7.11
  • Stock P/E
  • Book Value ₹ 18.2
  • Dividend Yield 0.00 %
  • ROCE -9.27 %
  • ROE -17.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.51 times its book value

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.09% over past five years.
  • Company has a low return on equity of -22.7% over last 3 years.
  • Debtor days have increased from 39.6 to 114 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023
25.36 25.20 15.62 14.22 24.70 17.43 22.04 10.48 26.48 0.00 7.65 0.00 0.00
29.86 27.47 31.54 13.18 28.19 16.41 25.71 15.31 28.98 4.72 11.67 4.31 4.68
Operating Profit -4.50 -2.27 -15.92 1.04 -3.49 1.02 -3.67 -4.83 -2.50 -4.72 -4.02 -4.31 -4.68
OPM % -17.74% -9.01% -101.92% 7.31% -14.13% 5.85% -16.65% -46.09% -9.44% -52.55%
0.14 1.20 9.08 0.25 0.22 0.12 0.59 0.14 0.32 0.10 0.49 0.10 0.16
Interest 1.17 1.30 1.22 1.16 1.23 1.54 1.68 1.58 1.74 1.67 2.06 1.72 2.09
Depreciation 0.06 0.06 0.06 0.06 0.06 0.04 0.05 0.04 0.04 0.04 0.09 0.03 0.03
Profit before tax -5.59 -2.43 -8.12 0.07 -4.56 -0.44 -4.81 -6.31 -3.96 -6.33 -5.68 -5.96 -6.64
Tax % -30.77% -21.81% -19.46% -2,642.86% 105.26% -25.00% -11.02% -20.76% -22.22% -26.07% -31.69% -23.15% -26.05%
-3.87 -1.89 -6.53 1.93 -9.36 -0.33 -4.28 -5.00 -3.08 -4.68 -3.88 -4.59 -4.92
EPS in Rs -0.90 -0.44 -1.51 0.45 -2.17 -0.08 -0.99 -1.16 -0.71 -1.08 -0.90 -1.06 -1.14
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
46 173 203 146 128 124 35 84 67 85 78 45 8
41 164 191 143 132 111 43 93 77 106 83 63 25
Operating Profit 6 9 12 3 -4 13 -8 -9 -10 -21 -5 -18 -18
OPM % 12% 5% 6% 2.3% -3.1% 10% -23% -11% -16% -24% -6% -41% -232%
2 1 6 1 1 1 1 4 1 2 1 3 1
Interest 0 2 6 1 6 4 1 2 5 5 6 7 8
Depreciation 1 1 1 1 1 1 0 0 0 0 0 0 0
Profit before tax 6 7 11 2 -9 9 -8 -7 -14 -24 -10 -23 -25
Tax % -111% 27% 42% 26% -31% 29% -46% -21% -28% -25% -10% -25%
13 5 6 2 -6 7 -4 -6 -10 -18 -9 -17 -18
EPS in Rs 2.91 1.16 1.48 0.36 -1.44 1.51 -0.99 -1.34 -2.36 -4.19 -2.03 -3.95 -4.18
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: -13%
5 Years: 5%
3 Years: -13%
TTM: -90%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -31%
TTM: -42%
Stock Price CAGR
10 Years: -9%
5 Years: -29%
3 Years: -27%
1 Year: -55%
Return on Equity
10 Years: -12%
5 Years: -24%
3 Years: -23%
Last Year: -18%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 43 43 43 43 43 43 43 43 43 43 43 43 43
Reserves -15 -1 -3 -2 -8 -1 -6 -12 -23 -9 62 45 36
7 0 -1 -9 9 0 0 32 3 27 78 70 74
45 48 52 48 24 17 16 62 103 43 29 28 35
Total Liabilities 81 90 91 80 68 59 53 125 127 104 213 186 188
9 8 7 6 6 5 5 5 4 4 116 115 115
CWIP 1 0 0 0 0 0 0 0 0 32 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
71 82 84 74 63 53 48 120 122 68 97 70 73
Total Assets 81 90 91 80 68 59 53 125 127 104 213 186 188

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
5 31 -12 8 -9 -17 3 -32 34 12 -42 11
-0 0 0 0 1 0 -1 1 1 1 1 0
-3 -0 -6 -1 -2 -3 -1 31 -34 -12 45 -15
Net Cash Flow 2 31 -18 7 -10 -20 1 -1 1 0 3 -3
Free Cash Flow 5 32 -12 8 -9 -17 3 -32 34 12 -42 11
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 89% 338% -99% 229% 239% -132% -32% 344% -328% -56% 847% -59%

Ratios

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 209 2 47 34 37 19 167 318 96 0 5 114
Inventory Days 241 87 66 84 77 2 23 67 308 56 202 13
Days Payable 316 99 70 103 26 1 6 204 259 61 5 4
Cash Conversion Cycle 134 -9 43 16 88 19 185 181 145 -5 203 122
Working Capital Days -20 -20 21 20 28 -19 59 10 -108 -174 -227 -549
ROCE % 20% 23% 42% 9% -8% 31% -18% -11% -22% -46% -3% -9%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022
Electricity Consumption Standard per Lakh Doses of OPV
Units per Lakh Doses

Log in to view insights

Please log in to see hidden values.

Login
Light Diesel Oil Used in Boilers
Liters
Number of Revenue-Generating Segments
Count
OPV Revenue Share
% of total segment revenue
Total Electricity Purchased
Units

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25% 59.25%
40.75% 40.75% 40.75% 40.75% 40.75% 40.75% 40.75% 40.74% 40.74% 40.75% 40.75% 40.74%
No. of Shareholders 38,19536,79936,86936,32335,69535,44236,24235,55034,81834,20134,91035,313

Documents

Announcements

Annual reports